Table 1.
Distribution of outcomes in case of exposure.
Table 2.
Key parameters in the epidemiological model.
Table 3.
Estimates for the short term cost per case of pertussis infection (ranges used in sensitivity analyzes presented in parentheses).
Figure 1.
Average annual predicted costs of pertussis and vaccination from 2006 to 2106.
Table 4.
Cost-effectiveness results in the base case.
Figure 2.
Variation in pertussis incidence and costs according to the age at which the adult booster dose is administered (Childhood vaccination+adolescent+cocoon+1 booster dose for adult vaccination - steady-state situation).
Table 5.
Sensitivity analyzes on cost per discounted life year gained at steady state.